Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Consolidation pact between Rallybio and Avenzo Therapeutics establishes updated equity distribution and clinical financing

02/06/2026 Published by Pharma Biz

Public equity markets logged a significant upward move for biotech developer Rallybio Corp., with its stock price hitting 24-month trading... Read more

Tags: #M&A

Eli Lilly enters into $1.26 billion global licensing agreement with Hanmi Pharm for sonefpeglutide

02/06/2026 Published by Pharma Biz

U.S. pharmaceutical powerhouse Eli Lilly and Company and South Korea’s Hanmi Pharm have formalized a definitive licensing and commercialization agreement... Read more

Category: Uncategorized

Tags: #M&A

Servier acquires Edgewise’s muscular dystrophy business for up to $2.65 billion to drive neurology expansion

02/06/2026 Published by Pharma Biz

U.S. biotech developer Edgewise Therapeutics has entered into a definitive agreement to sell its muscular dystrophy drug candidate and related... Read more

Category: Uncategorized

Tags: #M&A

FDA approves Shionogi’s Xocova, establishing the first oral post-exposure preventative for COVID-19 in the US

02/06/2026 Published by Pharma Biz

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to Shionogi’s antiviral medication, Xocova (ensitrelvir), specifically... Read more

Category: Uncategorized

Tags: #Global Trends

Vietnamese Government convenes meeting to consolidate food safety management apparatus into a single focal agency

02/06/2026 Published by Pharma Biz

On the afternoon of June 1, 2026, at the Government Headquarters, Member of the Secretariat of the Central Committee and... Read more

Category: Uncategorized

Tags: #Vietnam

Pharmacity secures profitability following comprehensive portfolio restructuring and AI integration

02/06/2026 Published by Pharma Biz

Speaking at the Vietnam Innovation Investment Forum (VIPC Summit) 2026 held on May 28 in Ho Chi Minh City, Deepanshu... Read more

Category: Uncategorized

Tags: #Vietnam

Pharmacity secures profitability following comprehensive portfolio restructuring and AI integration

02/06/2026 Published by Pharma Biz

Speaking at the Vietnam Innovation Investment Forum (VIPC Summit) 2026 held on May 28 in Ho Chi Minh City, Deepanshu... Read more

Category: Uncategorized

Tags: #Vietnam

Novartis’ experimental radiopharma therapy showcases clinical efficacy in advanced prostate cancer trial

01/06/2026 Published by Pharma Biz

Swiss pharmaceutical flagship Novartis announced Sunday that early-stage clinical data monitoring its experimental actinium-based radioligand candidate demonstrated pronounced anti-tumor activity... Read more

Category: Uncategorized

Tags: #Global Trends

J&J’s prostate cancer therapeutic Erleada significantly limits metastasis and mortality risks in late-stage registration trial

01/06/2026 Published by Pharma Biz

Healthcare conglomerate Johnson & Johnson (J&J) announced definitive clinical data from a pivotal late-stage Phase III trial showcasing that its... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 20 Page 21 Page 22 … Page 157 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members